Zenobia C. D'costa
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Journal: Oncogene
Published: August 08, 2018
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy.
Journal: EMBO molecular medicine
Published: December 10, 2016
Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
Journal: Oncotarget
Published: April 20, 2016
The identification of a novel role for BRCA1 in regulating RNA polymerase I transcription.
Journal: Oncotarget
Published: April 19, 2016
The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.
Journal: Oncotarget
Published: September 21, 2015
Development of a potent and selective cell penetrant Legumain inhibitor.
Journal: Bioorganic & medicinal chemistry letters
Published: September 10, 2015
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
Journal: Oncotarget
Published: April 19, 2014
P3 SAR exploration of biphenyl carbamate based Legumain inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: January 30, 2014
Last Updated: 09/26/2026